Preeclampsia triggered by an overdose of gene activity

October 6, 2017, Max Delbrück Center for Molecular Medicine
Credit: Max Delbrück Center for Molecular Medicine

Preeclampsia is the most dangerous form of hypertension during a pregnancy and can be fatal for both mother and child. Though it is known to originate in the placenta, the root causes remain largely a mystery. An international research team led by the Max Delbrück Center for Molecular Medicine (MDC) has recently published new findings in the scientific journal Circulation, which reveal that preeclampsia is not in fact a single disease caused solely by genetic factors. Their tests on placenta samples have shown that epigenetically regulated genes play an important role. The Berlin research team also developed an in vitro model of the disorder which demonstrates the dysregulation of an important transcription factor.

The research team compared placental tissue samples and the genetic makeup of patients with with those of healthy women. The entirety of their genetic material was analyzed for genes that are differentially expressed in the preeclamptic versus healthy placentas and checked for disrupted genomic imprinting, which refers to certain genes that are "switched off" on either the paternal or maternal chromosome. This led them to identify the so-called DLX5 gene as a significant transcription factor involved in regulating the activity of other in preeclampsia. This gene is usually turned off - or epigenetically "imprinted" - on the paternal chromosome, controlling the proper dosage of gene expression. Due to loss of the regulation by imprinting, DLX5 was strongly upregulated in ca. 70 percent of the samples studied from preeclampsia patients, meaning the gene was switched on in these cases. This study is the first to demonstrate that a change in epigenetic gene regulation by imprinting can contribute to preeclampsia. The scientists also found three separate types of preeclampsia, supporting the view that preeclampsia is a complex disease.

The study involved close collaboration between basic research and clinical institutes. Participants included research groups led by the molecular biologist Dr. Zsuzsanna Izsvák of the MDC and Dr. Ralf Dechend of the Helios clinic in Berlin-Buch and the Experimental and Clinical Research Center (ECRC), a joint institution of MDC and Charité - Universitätsmedizin Berlin. The interdisciplinary team also included researchers from the Berlin Institute of Health (BIH) and the evolution biologist Laurence Hurst from University of Bath, UK.

Development of the in vitro cell model for preeclampsia

Preeclampsia affects around four percent of all pregnancies. Its main symptoms are high blood pressure and protein in the urine. If these symptoms reach dangerous levels, delivery must be induced prematurely. In Germany, preeclampsia causes as many as 20,000 premature births every year. The condition occurs only in humans, and no robust animal models have been proven suitable. The development of an in vitro model is therefore of vital importance.

Here, the Berlin-based research group achieved a real breakthrough. In their in vitro model, they increased the activity of the DLX5 gene in the trophoblastic cells - the outer layer of the embryonic cell that later builds the placenta. The cells showed an increased stress response, which is also observed in patients. This cellular system will now allow for further investigation into the different types of preeclampsia and for new medications and active agents to be found.

Why does this condition only affect humans?

Izsvák and Dechend are already planning the next steps: "We want to find out why this condition occurs only in humans," says Izsvák. "We also hope to find biomarkers for the three types of preeclampsia we have identified," adds Ralf Dechend. "These will help diagnosing or predicting the disease before the actual illness develops."

Explore further: Fetal genes can increase the risk of illness during pregnancy

More information: Julianna Zadora et al, Disturbed Placental Imprinting in Preeclampsia Leads to Altered Expression of DLX5, a Human-Specific Early Trophoblast Marker, Circulation (2017). DOI: 10.1161/CIRCULATIONAHA.117.028110

Related Stories

Fetal genes can increase the risk of illness during pregnancy

September 1, 2017
A mother's risk of preeclampsia, a potentially life-threatening illness associated with pregnancy, can be linked in some cases to genes from her fetus. For the first time, a relationship has been found between fetal genes ...

Lack of a hormone in pregnant mice linked to preeclampsia

June 30, 2017
(Medical Xpress)—A team of researchers from Singapore, the Netherlands and Turkey has isolated a hormone in pregnant mice that appears to be associated with preeclampsia—a pregnancy-related condition characterized by ...

Reflux tablet could save 60,000 lives lost to preeclampsia

January 24, 2017
An international collaboration led by the Translational Obstetrics Group (TOG) based at Mercy Hospital for Women has discovered a treatment that could save many of the 60,000 lives lost each year to preeclampsia.

Altered immune cells may both contribute to preeclampsia and offer new hope for treatment

April 24, 2017
Though the exact cascade of events leading to preeclampsia is unknown, reduced blood flow to the placenta (placental ischemia) is commonly thought to be a factor that contributes to the development of the pregnancy-related ...

Preeclampsia may boost heart disease risk by altering blood vessels

September 12, 2017
Preeclampsia may permanently change the blood vessels of women who experience the condition during pregnancy, boosting their lifelong risk for cardiovascular disease, according to Penn State researchers.

Study provides insights on preeclampsia

July 20, 2017
Researchers have developed a method that could help rapidly diagnose preeclampsia in pregnant women. They have also uncovered clues that might help explain why women with preeclampsia often develop an abnormal amount of protein ...

Recommended for you

Vaginal estrogen tablets, moisturizers and placebo gel all can improve vaginal discomfort

March 19, 2018
A clinical trial comparing two treatments for postmenopausal vaginal discomfort - low-dose vaginal estrogen and a vaginal moisturizer - to placebo treatments found that both produced symptom improvements similar to those ...

Discovery promises improved diagnosis and understanding of endometriosis

March 19, 2018
Feinstein Institute for Medical Research scientists announced an experimental, rapid and non-invasive way to diagnose endometriosis, which may lead to earlier and more effective treatments for this disorder that affects approximately ...

Frozen embryos more successful for conceiving during IVF

March 19, 2018
A new study carried out by a research team at The University of Western Australia and Fertility Specialists of Western Australia has found that women undergoing IVF who have had embryos fail to implant have more success using ...

Alomst 70 percent of 103 genes linked to prenatal death affect the placenta

March 14, 2018
The role of the placenta in healthy fetal development is being seriously under-appreciated according to a new paper published today (14th March). The study was part of the Wellcome Trust-funded "Deciphering the Mechanisms ...

New research shows why babies need to move in the womb

March 12, 2018
Scientists have just discovered why babies need to move in the womb to develop strong bones and joints. It turns out there are some key molecular interactions that are stimulated by movement and which guide the cells and ...

Labour–inducing drugs put to the test

February 27, 2018
Researchers comparing the use of two drugs for pregnant women who do not go into labour shortly after their waters break have found both are reasonable options.


Adjust slider to filter visible comments by rank

Display comments: newest first

3 / 5 (1) Oct 07, 2017
Restless leg syndrome and pre-eclampsia leg problems seem to have many commonalities. One commonality is a tendency to an elevated BP reading - both during and after "initial" occurrence.

Both circumstance seem treatable with high-pressure deep-tissue massage as described by Dr. David Simons in his 1970's translation of early 1900's research by 12 German Research Doctors.

I would suggest as a hypothesis: Overuse in lower leg musculature causes muscle spindle cells to become overactive - causing chronic firing and shortened muscle structure - resulting in edema caused pressure which reduces capillary blood flow capacity - puts pressure on nerve tissue - and creates a chronic hyper tonus. Increased pressure causes a feed back ( possibly to Renal enervation ) which causes the heart to increase BP to provide sufficient blood flow to enable escape from a predator - but there is no predator. This would suggest why Renal nerve Ablation works in some cases. An avenue to research?
not rated yet Oct 07, 2017
So why does treatment with Magnesium salts often ease symptoms ??

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.